Dexmedetomidine: A Review of Its Use for Sedation in the Intensive Care Setting
Top Cited Papers
- 11 June 2015
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 75 (10), 1119-1130
- https://doi.org/10.1007/s40265-015-0419-5
Abstract
Dexmedetomidine (Dexdor®) is a highly selective α2-adrenoceptor agonist. It has sedative, analgesic and opioid-sparing effects and is suitable for short- and longer-term sedation in an intensive care setting. In the randomized, double-blind, multicentre MIDEX and PRODEX trials, longer-term sedation with dexmedetomidine was noninferior to midazolam and propofol in terms of time spent at the target sedation range, as well as being associated with a shorter time to extubation than midazolam or propofol, and a shorter duration of mechanical ventilation than midazolam. Patients receiving dexmedetomidine were also easier to rouse, more co-operative and better able to communicate than patients receiving midazolam or propofol. Dexmedetomidine had beneficial effects on delirium in some randomized, controlled trials (e.g. patients receiving dexmedetomidine were less likely to experience delirium than patients receiving midazolam, propofol or remifentanil and had more delirium- and coma-free days than patients receiving lorazepam). Intravenous dexmedetomidine had an acceptable tolerability profile; hypotension, hypertension and bradycardia were the most commonly reported adverse reactions. In conclusion, dexmedetomidine is an important option for sedation in the intensive care setting.Keywords
This publication has 61 references indexed in Scilit:
- Population Pharmacokinetics of Dexmedetomidine in Critically Ill PatientsClinical Drug Investigation, 2013
- Safety and Effectiveness of Dexmedetomidine in the Pediatric Intensive Care Unit (SAD–PICU)The Canadian Journal of Hospital Pharmacy, 2013
- CYP2A6 genetic variation and dexmedetomidine dispositionEuropean Journal of Clinical Pharmacology, 2012
- DexmedetomidineDrugs, 2011
- Dexmedetomidine: new insightsEuropean Journal of Anaesthesiology, 2011
- Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trialCritical Care, 2010
- Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trialCritical Care, 2009
- Electroencephalogram spindle activity during dexmedetomidine sedation and physiological sleepActa Anaesthesiologica Scandinavica, 2007
- Dexmedetomidine-Induced Sedation in Volunteers Decreases Regional and Global Cerebral Blood FlowAnesthesia & Analgesia, 2002
- Direct Coronary and Cerebral Vascular Responses to DexmedetomidineAnesthesiology, 1992